Results from the Cox proportional hazard model (HR) analysis, the DPP-4 inhibitor was associated with a neutral risk of acute pancreatitis HR 0.68; 95% CI: 0.42–1.09. The gene discussed is DPP4; the disease is acute pancreatitis.